-
1 Comment
Beijing Beilu Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 11.0% below its 200 day moving average.
From a valuation standpoint, the stock is 43.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.4.
Beijing Beilu Pharmaceutical Co., Ltd's total revenue sank by 3.6% to $204M since the same quarter in the previous year.
Its net income has dropped by 91.9% to $14M since the same quarter in the previous year.
Finally, its free cash flow fell by 96.0% to $1M since the same quarter in the previous year.
Based on the above factors, Beijing Beilu Pharmaceutical Co., Ltd gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| ISIN | CNE000001QK9 |
| Exchange | SHE |
| CurrencyCode | CNY |
| Market Cap | 5B |
|---|---|
| PE Ratio | 246.75 |
| Beta | 0.21 |
| Target Price | None |
| Dividend Yield | 0.5% |
Beijing Beilu Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company provides contrast agents, such as Gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; Iohexol injection, iopamidol injection, and iodixanol injection for CT contrast. Its hypoglycemic product line includes Glimepiride tablets and repaglinide tablets. The original drug product line for the central nervous system includes Jiuwei Zhenxin Granule. It also offers an API product line for contrast agent APIs, including gadolinium-based agents like Gadopentetate dimeglumine and gadobutrol, as well as iodine-based agents such as Iohexol, ioversol, iodixanol, iopromide, and iopamidol. In addition, the company provides oral anti-diabetic drugs. Beijing Beilu Pharmaceutical Co., Ltd. was founded in 1992 and is headquartered in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300016.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
